OPW
TEVA icon

Oxler Private Wealth’s Teva Pharmaceuticals TEVA Stock Holding History

Oxler Private Wealth’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-700
Closed -$5.65K – 304
2022
Q3 		$5.65K Hold
700
– – ﹤0.01% 397
2022
Q2 		$5.26K Buy
+700
New +$6.1K ﹤0.01% 226
2021
Q1 		– Sell
-1,000
Closed -$9K – 203
2020
Q4 		$9K Buy
+1,000
New +$9.58K 0.01% 211

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Oxler Private Wealth's TEVA Position: Q4 2022 in Review

Oxler Private Wealth sold out of Teva Pharmaceuticals (TEVA) in Q4 2022, closing a stake of 700 shares — an estimated $5.65K sold.

Oxler Private Wealth first reported a position in TEVA in Q4 2020 and held it in 3 quarters. The position peaked at $9K in Q4 2020. 422 funds tracked by Wall St. Rank hold TEVA as of Q4 2022.

  • Oxler Private Wealth reported no remaining Teva Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Oxler Private Wealth sold 700 Teva Pharmaceuticals shares in Q4 2022, an estimated $5.65K.
  • Oxler Private Wealth first reported a position in Teva Pharmaceuticals in Q4 2020 and held it in 3 quarters.
  • Oxler Private Wealth's Teva Pharmaceuticals position peaked at $9K in Q4 2020.
  • 422 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2022.

Based on Oxler Private Wealth's 13F filing for Q4 2022, filed 13 Feb 2023.